Lionheart Holdings (CUB) EBITDA (2025)

Lionheart Holdings (CUB) posted quarterly EBITDA of -$199829.0 for Q4 2025, down 1.93% quarter-over-quarter from -$196049.0 in Q3 2025.

Lionheart Holdings (CUB) EBITDA (2025) Analysis & Trends

Lionheart Holdings' EBITDA history runs 1 years deep, the most recent figure standing at -$199829.0 for Q4 2025.

In Q4 2025, EBITDA changed N/A year-over-year to -$199829.0; the TTM figure through Dec 2025 stood at -$874604.0 (changed N/A YoY), while the FY2025 annual figure was -$874604.0, down 76.53% from the prior year.
EBITDA for Q4 2025 stood at -$199829.0, down from -$196049.0 in the prior quarter.
The five-year high for EBITDA was -$196049.0 in Q3 2025, with the low at -$248561.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA (Qtr)
1	Launch Two Acquisition	557.86 Mn	557.86 Mn	-	-194,528.00
2	Drugs Made In America Acquisition	507.00 Mn	507.00 Mn	-	-112,227.00
3	Cantor Equity Partners IV	467.55 Mn	467.55 Mn	-	-174,182.00
4	GP-Act III Acquisition	401.06 Mn	401.06 Mn	-	-1.47 Mn
5	Aldel Financial	397.49 Mn	397.49 Mn	-	-115,742.00
6	Gores Holdings X	381.05 Mn	380.85 Mn	-	-1.35 Mn
7	Agriculture & Natural Solutions Acquisition	377.29 Mn	377.04 Mn	-	-
8	Blue Water Acquisition Corp. III	342.12 Mn	342.08 Mn	-	-197,949.00
9	Berto Acquisition	313.96 Mn	313.81 Mn	-	-1.62 Mn
10	Lionheart Holdings	253.90 Mn	253.90 Mn	-	-6.82 Mn

Download Data